Literature DB >> 1851801

Mutants of Streptococcus gordonii Challis over-producing glucosyltransferase.

R J Haisman1, H F Jenkinson.   

Abstract

Two mutants of Streptococcus gordonii which over-produced extracellular polysaccharide when grown on sucrose-containing medium were isolated after mutagenesis of strain Challis with ethyl methanesulphonate. The mutants, designated strains OB20 and OB30, expressed 2.6-fold and 4.7-fold respectively more glucosyltransferase (GTF) activities than the wild-type strain. Transformation experiments suggested that the two mutants carried different mutations, denoted gtf-20 and gtf-30. A double mutant (gtf-20 gtf-30) was constructed and this strain produced 6.4-fold more GTF. Enzymes from wild-type and mutant strains were biochemically indistinguishable and they synthesized structurally identical glucans. Increasing the Na+ concentration of the bacterial growth medium reduced GTF production in all strains by about 60%. Tween 80 also inhibited enzyme production and more specifically reduced GTF synthesis by the mutants. The mutations gtf-20 and gtf-30 appear to define separate genetic loci involved in regulating expression of GTF activity in S. gordonii.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851801     DOI: 10.1099/00221287-137-3-483

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  17 in total

1.  Genetic analysis of the rgg-gtfG junctional region and its role in Streptococcus gordonii glucosyltransferase activity.

Authors:  M M Vickerman; P E Minick
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Identification of a gene, rgg, which regulates expression of glucosyltransferase and influences the Spp phenotype of Streptococcus gordonii Challis.

Authors:  M C Sulavik; G Tardif; D B Clewell
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

3.  LuxS-based signaling in Streptococcus gordonii: autoinducer 2 controls carbohydrate metabolism and biofilm formation with Porphyromonas gingivalis.

Authors:  Roderick McNab; Suzannah K Ford; Azza El-Sabaeny; Bruno Barbieri; Guy S Cook; Richard J Lamont
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

4.  Extracellular DNA and lipoteichoic acids interact with exopolysaccharides in the extracellular matrix of Streptococcus mutans biofilms.

Authors:  Midian C Castillo Pedraza; Tatiana F Novais; Roberta C Faustoferri; Robert G Quivey; Anton Terekhov; Bruce R Hamaker; Marlise I Klein
Journal:  Biofouling       Date:  2017-09-25       Impact factor: 3.209

5.  Deletions in the carboxyl-terminal region of Streptococcus gordonii glucosyltransferase affect cell-associated enzyme activity and sucrose-associated accumulation of growing cells.

Authors:  M M Vickerman; D B Clewell
Journal:  Appl Environ Microbiol       Date:  1997-05       Impact factor: 4.792

6.  Multiple adhesin proteins on the cell surface of Streptococcus gordonii are involved in adhesion to human fibronectin.

Authors:  Nicholas S Jakubovics; Jane L Brittan; Lindsay C Dutton; Howard F Jenkinson
Journal:  Microbiology (Reading)       Date:  2009-08-06       Impact factor: 2.777

7.  Rgg is a positive transcriptional regulator of the Streptococcus gordonii gtfG gene.

Authors:  M C Sulavik; D B Clewell
Journal:  J Bacteriol       Date:  1996-10       Impact factor: 3.490

8.  Adhesion of glucosyltransferase phase variants to Streptococcus gordonii bacterium-glucan substrata may involve lipoteichoic acid.

Authors:  M M Vickerman; G W Jones
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  Adherence of Candida albicans to a cell surface polysaccharide receptor on Streptococcus gordonii.

Authors:  A R Holmes; P K Gopal; H F Jenkinson
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  A binding-lipoprotein-dependent oligopeptide transport system in Streptococcus gordonii essential for uptake of hexa- and heptapeptides.

Authors:  H F Jenkinson; R A Baker; G W Tannock
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.